Nuzenio

Tradingview Tg Therapeutics

Tradingview Tg Therapeutics entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 10 latest news signals 1 publisher sources 100/100 entity strength

Latest news

TG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:02:08 GMTTGTX: Record BRIUMVI growth and raised guidance highlight a strong quarter and expanding franchise - TradingViewTradingView · Mon, 03 Aug 2026 14:37:33 GMTTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 03 Aug 2026 13:31:38 GMTTg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance - TradingViewTradingView · Mon, 03 Aug 2026 13:22:51 GMTWeekly Recap: B. Riley raises TG Therapeutics target to $86 and Aug 3 Q2 call - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTTG Therapeutics reports Q2 2026 revenue ~$240M, raises 2026 BRIUMVI U.S. revenue guidance - TradingViewTradingView · Mon, 03 Aug 2026 11:23:01 GMTTGTX: Q2 2026 revenue surged 64% year-over-year, driving raised full-year guidance and strong liquidity - TradingViewTradingView · Mon, 03 Aug 2026 11:03:24 GMTTG Therapeutics, Inc. Revenue Breakdown – NASDAQ:TGTX - TradingViewTradingView · Sat, 01 Aug 2026 03:24:44 GMT

Timeline

Wed, 05 Aug 2026 21:02:08 GMTTG Therapeutics 2026: Revenue $240.34M, EPS $0.05— 10-Q Summary - TradingView
Mon, 03 Aug 2026 14:37:33 GMTTGTX: Record BRIUMVI growth and raised guidance highlight a strong quarter and expanding franchise - TradingView
Mon, 03 Aug 2026 13:31:38 GMTTG Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Mon, 03 Aug 2026 13:22:51 GMTTg Therapeutics Reports Second Quarter 2026 Financial Results And Raises Briumvi® Revenue Guidance - TradingView
Mon, 03 Aug 2026 11:33:04 GMTWeekly Recap: B. Riley raises TG Therapeutics target to $86 and Aug 3 Q2 call - TradingView
Mon, 03 Aug 2026 11:23:01 GMTTG Therapeutics reports Q2 2026 revenue ~$240M, raises 2026 BRIUMVI U.S. revenue guidance - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Tg Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.